Correlation Between Entravision Communications and Dianthus Therapeutics

Can any of the company-specific risk be diversified away by investing in both Entravision Communications and Dianthus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entravision Communications and Dianthus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Entravision Communications and Dianthus Therapeutics, you can compare the effects of market volatilities on Entravision Communications and Dianthus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entravision Communications with a short position of Dianthus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entravision Communications and Dianthus Therapeutics.

Diversification Opportunities for Entravision Communications and Dianthus Therapeutics

-0.49

Correlation Coefficient

Entravision Communications  Dianthus Therapeutics

Very good diversification

The 3 months correlation between Entravision and Dianthus is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Entravision Communications and Dianthus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dianthus Therapeutics and Entravision Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entravision Communications are associated (or correlated) with Dianthus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dianthus Therapeutics has no effect on the direction of Entravision Communications i.e., Entravision Communications and Dianthus Therapeutics go up and down completely randomly.

Pair Corralation between Entravision Communications and Dianthus Therapeutics

Considering the 90-day investment horizon Entravision Communications is expected to generate 1.93 times less return on investment than Dianthus Therapeutics. But when comparing it to its historical volatility, Entravision Communications is 1.23 times less risky than Dianthus Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Dianthus Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  2,366  in Dianthus Therapeutics on October 6, 2024 and sell it today you would earn a total of  146.00  from holding Dianthus Therapeutics or generate 6.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Entravision Communications  vs.  Dianthus Therapeutics

Entravision Communications

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Entravision Communications are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Entravision Communications exhibited solid returns over the last few months and may actually be approaching a breakup point.

Dianthus Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Dianthus Therapeutics is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Entravision Communications and Dianthus Therapeutics

The main advantage of trading using opposite Entravision Communications and Dianthus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entravision Communications position performs unexpectedly, Dianthus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dianthus Therapeutics will offset losses from the drop in Dianthus Therapeutics' long position.

The idea behind Entravision Communications and Dianthus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.